Hirsutism Treatment Market Size was valued at USD 3.55 Billion in 2023. The Global Hirsutism Treatment industry is projected to grow from USD 3.84 Billion in 2024 to USD 7.12 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.35% during the forecast period (2024 - 2032).Hirsutism is a condition of excessive, unwanted, and male-pattern hair growth in women. Hirsutism results in unwanted hair growth on body areas such as face, stomach, back, and chest. About 5% of US women have hirsutism.
Increasing procedures, growing awareness of treatments, increasing personal care expenditure, and technological advancement are major factors for the market growth. Increasing R&D and new product development are also important factors for market growth.
BioSyent Inc. is pleased to announce that they have sent the first shipments of the pharmaceutical product Inofolic® to Canada in August 2023 through their subsidiary, BioSyent pharma inc., Inofolic® is a health product made from myo-inositol and folic acid contained in a particular soft gel that assists women having PCOS. A condition affecting an approximate of about 1.4 million womenii; hormonal imbalance (PCOS) affects various aspects of a woman’s body. Including insulin resistance, difficulty in conceiving, menstrual disorder and skin manifestations like pimples and hirsutism (excessive hair growth), alopecia.
In June 2022, Halozyme Therapeutics, Inc. announced commercial availability of TLANDO™ their oral testosterone replacement therapy drug for treatment of men with primary or hypogonadotropic hypogonadism due to deficiencies or absence of endogenous testosterone The US Food and Drug Administration approved this medication on 28th March.Male hypogonadism means that the body does not produce enough testosterone.
In October 2022, Sensus Healthcare, Inc. displayed their latest portable Sensus Silk hair removal system with blended wavelengths at the Fall Clinical Dermatology Conference held in Las Vegas; this system emits light vertically into the skin which means it maintains laser density over a given area, allowing deep penetration and better distribution of energy as well as making its deposition uniform inside.
October 2022: Endymed Ltd has been granted FDA approval to sell and market Pure Laser which is a new hair removing laser device that can be used on all types of skin sold in the USA. This move enables the company to extend its spectrum of aesthetic treatments for both partners and customers of the Company.
Lumenis introduced Splendor X to the UK market in March 2022. This versatile device is suitable for all Fitzpatrick skin types and addresses men’s and women’s needs alike.
ALLERGAN has segmented its business into US specialized therapeutics, US general medicine, international and others. The goods that are being offered by the company include VANIQA. It is an ointment which contains eflornithine hydrochloride monohydrate (150 mg/g) equivalent to 13.9% w/w anhydrous eflornithine hydrochloride.It is prescribed for excessive facial hair growth in women.
Hirsutism treatment market has been segmented on the basis of type which comprises of idiopathic hirsutism, secondary hirsutism, and others.
On the basis of diagnosis, the market is segmented into blood tests, imaging tests, physical examination, and others. Blood tests sub-segmented into testosterone level test, DHEA-sulfate test, and others. Imaging test sub-segmented into ultrasound, CT scan, and others. Physical examination sub-segmented into inspection, auscultation, palpation and percussion, and others.
On the basis of treatments, the market has been segmented into medications, procedures, and others. Medication is sub-segmented into oral contraceptives, anti-androgens, topical cream, and others. Procedures include electrolysis, laser therapy, and others.
On the basis of end user, it is segmented into hospitals and clinics, medical research centers, academic institutes, and others.
Considering the global scenario of the market, America is holding the largest market share. The Americas are second largest hirsutism treatment market, especially developed North America region is holding the largest market share not only in America but also in hirsutism treatment market. While UK is believed to be the fastest growing market for hirsutism treatment in European region. Factors like technological advancement, and increasing demand for treatments are leading the growth for this region. Europe is the second largest market for hirsutism. Due to Increasing awareness, rising healthcare expenditure, availability of affordable healthcare facilities, Asia Pacific is fastest growing region in hirsutism market. Middle East and Africa contributes least market share and expected to grow slower than global average growth rate.
The report for Hirsutism treatment Marketof Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions
Key players for Hirsutism treatment market:
Study objectives of hirsutism treatment market:
Intended Audience:
| Report Attribute/Metric | Details |
| Market Size | USD 7.12 Billion |
| CAGR | 9.35 % (2024-2032) |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Type, By Diagnosis, By Treatment, By End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Bayer AG (Germany), Bristol-Myers Squibb Company (US), AbbVie Inc. (US), Allergan (Republic of Ireland), Sun Pharmaceutical Industries Ltd. (India), Jubilant Cadista (US), Pfizer Inc. (US), and others. |
| Key Market Opportunities | Innovations in hormonal therapies and laser-based treatments offer promising market potential in hirsutism management. |
| Key Market Drivers | Increased public awareness of hirsutism is leading more women to seek diagnosis and treatment. |
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
